ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,351Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 5176

$2.37M Total Retail Price of All Prescriptions

Rank: 34 out of 5176

578 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 31,061 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,459 1,414 1 16
AMLODIPINE BESYLATE 1,188 1,143 2 2
ATENOLOL 911 867 3 12
METFORMIN HCL 754 739 4 7
METOPROLOL SUCCINATE 753 745 5 11
DIOVAN 732 698 6 19
TAMSULOSIN HCL 716 694 7 20
COUMADIN 705 705 10 8 112
PLAVIX 689 681 9 29
JANUVIA 658 632 10 25
ZOLPIDEM TARTRATE 590 579 11 17
CLOPIDOGREL 573 557 12 26
OMEPRAZOLE 559 509 13 3
SIMVASTATIN 554 528 14 1
FUROSEMIDE 533 516 15 8
SYNTHROID 523 500 16 33
LOSARTAN POTASSIUM 484 459 17 14
METOPROLOL TARTRATE 474 440 18 6
LISINOPRIL 464 433 19 5
ATORVASTATIN CALCIUM 395 384 20 9
DIOVAN HCT 357 346 21 39
RANITIDINE HCL 354 347 22 36
CRESTOR 338 333 23 15
HYDROCHLOROTHIAZIDE 332 279 24 10
PRAVASTATIN SODIUM 314 314 25 23
DIGOXIN 312 312 26 56
LOSARTAN-HYDROCHLOROTHIAZIDE 310 283 27 35
CARVEDILOL 300 288 28 24
ALLOPURINOL 286 278 29 41
DILTIAZEM 24HR CD 265 260 30 119
ACTOS 249 239 31 85
AVODART 244 244 32 107
LOVAZA 243 230 33 43
GLIPIZIDE XL 236 223 34 83
LIDODERM 232 203 35 59
ISOSORBIDE MONONITRATE ER 230 230 36 44
MELOXICAM 226 221 37 53
BENICAR HCT 218 218 38 110
LIPITOR 212 209 39 51
MECLIZINE HCL 209 202 40 81
PROCTOZONE-HC 200 190 41 171
VOLTAREN 199 192 42 97
ENALAPRIL MALEATE 193 186 43 22
CILOSTAZOL 185 185 44 206
CLOTRIMAZOLE-BETAMETHASONE 183 179 45 94
ATENOLOL-CHLORTHALIDONE 180 170 46 161
CREON 177 168 47 111
DONEPEZIL HCL 177 177 47 28
GABAPENTIN 177 173 47 21
BENICAR 168 168 50 100
GLIMEPIRIDE 167 157 51 37
EVISTA 162 160 52 65
ALENDRONATE SODIUM 162 149 52 18
NAMENDA 155 155 54 47
POTASSIUM CHLORIDE 151 151 55 34
RAMIPRIL 150 150 56 50
WARFARIN SODIUM 149 147 57 13
AZITHROMYCIN 148 138 58 42
AMMONIUM LACTATE 146 144 59 91
LACTULOSE 144 144 60 87
SYMBICORT 143 139 61 120
ADVAIR DISKUS 142 141 62 32
TORSEMIDE 141 141 63 184
SINGULAIR 140 138 64 62
NITROSTAT 140 140 64 205
CLONIDINE HCL 132 131 66 79
SERTRALINE HCL 131 123 67 30
LANSOPRAZOLE 123 118 68 113
POLYETHYLENE GLYCOL 3350 123 111 68 74
LYRICA 122 122 70 133
TRAMADOL HCL 122 118 70 40
FLUTICASONE PROPIONATE 119 104 72 38
COLCRYS 118 118 73 170
ESCITALOPRAM OXALATE 117 106 74 89
FINASTERIDE 116 116 75 69
SOLARAZE 114 113 76 157
NITROGLYCERIN PATCH 109 109 77 149
HYDROCODONE-ACETAMINOPHEN 109 98 S3 77 27
BUSPIRONE HCL 108 108 79 183
QUINAPRIL HCL 104 104 80 82
KLOR-CON 10 101 95 81 225
PAROXETINE HCL 101 100 81 93
CARTIA XT 100 100 83 406
ALCOHOL SWABS 100 100 83 115
CLONIDINE 99 99 85 295
DEXILANT 97 94 86 118
VERAPAMIL ER 96 85 87 155
TEKTURNA 96 96 87 255
DICYCLOMINE HCL 95 89 89 224
GLIPIZIDE ER 94 87 90 117
LUNESTA 93 93 91 242
LEVOTHYROXINE SODIUM 91 69 92 4
CELEBREX 89 76 93 80
DILTIAZEM 24HR ER 89 89 93 136
FAMOTIDINE 89 83 93 58
NIFEDIPINE ER 87 87 96 48
HYDROCORTISONE VALERATE 87 86 96 319
MICARDIS 84 84 98 154
TRAMADOL HCL-ACETAMINOPHEN 82 82 99 116
FLUOXETINE HCL 81 73 100 132
SPIRIVA 80 80 101 54
LANTUS 80 80 101 66
ACETAMINOPHEN-CODEINE 79 79 S3 103 127
CITALOPRAM HBR 76 73 104 31
PRIMIDONE 72 72 105 425
PIOGLITAZONE HCL 72 67 R 105 237
PROAIR HFA 72 62 105 60
ACTONEL 69 69 108 134
LIDOCAINE 69 68 108 179
OLANZAPINE 69 63 108 140
QUETIAPINE FUMARATE 67 67 111 75
HYDRALAZINE HCL 65 65 112 73
PROPRANOLOL HCL 65 61 112 199
LOPERAMIDE 62 62 114 329
ACARBOSE 61 57 115 223
AZELASTINE HCL 60 57 116 267
SINGLE USE SWAB 60 59 116 108
LEVETIRACETAM 60 38 116 92
MONTELUKAST SODIUM 59 55 119 123
RANEXA 59 59 119 167
SPIRONOLACTONE 56 56 121 88
PREDNISONE 55 55 122 52
DOXAZOSIN MESYLATE 54 53 123 103
LANTUS SOLOSTAR 54 45 123 70
PANTOPRAZOLE SODIUM 53 44 125 61
GLYBURIDE-METFORMIN HCL 52 52 R 126 76
CHLORHEXIDINE GLUCONATE 52 52 126 202
MICARDIS HCT 50 50 128 180
COMBIVENT 50 49 128 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.